Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Investing

Pfizer : PFE

All Pfizer Articles

1508 Articles

Douglas A. McIntyre | Jun 20, 2007 at 7:39 PM EDT

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Coley Pharmaceuticals (COLY) is yet another small-cap biopharma one-trick pony that fell apart like a cheap clock. Pfizer (PFE) had…

Douglas A. McIntyre | Jun 20, 2007 at 4:37 PM EDT

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM…

Douglas A. McIntyre | Jun 12, 2007 at 5:53 PM EDT

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said…

Douglas A. McIntyre | Jun 8, 2007 at 2:14 PM EDT

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Stock Tickers: AAPL, GOOG, RIMM, BA, UTX, ATI, RTP, RIO, FLR, SGR, PEP, KO, BUD, CAG, HNZ, CPB, HRL, K,…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 22, 2007 at 5:25 PM EDT

DJIA Components Huge Rise in Short Selling (MAY-07)

We reviewed various short selling trends and noticed that most sectors were mixed to up as the April to May…

Douglas A. McIntyre | May 22, 2007 at 4:36 PM EDT

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw…

Douglas A. McIntyre | May 21, 2007 at 6:37 AM EDT

Pre-Market Stock News (May 21, 2007)

(ASD) American Standard is reaffirming guidance.(AT) Alltel agreed to a $27.5 Billion buyout offer, or $71.50 per share.(CATT) Catapult believes…

1 … 99 100 101

Pfizer : PFE

All Pfizer Articles

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Biotechs & Pharmas Bracing For ASCO Annual Meeting

DJIA Components Huge Rise in Short Selling (MAY-07)

Short Selling Up in Drug & Medical Stocks

Pre-Market Stock News (May 21, 2007)

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

5 Solid Dividend Stocks to Buy in July

Tesla Robotaxi Success Endangered By Regulators

“You’re Building a Google in 2 Years,” Why One Energy Analyst Warns The U.S. Grid Is Not Ready For What’s Coming

You Claimed Social Security Back Pay This Year. It Just Nudged You Over the IRMAA Line.

How the Average Retiree's $330,186 Quietly Pushes Their Social Security Into Taxable Territory

Jim Cramer Says SK Hynix Analysts Must Raise Numbers: What It Means for the Biggest Nasdaq IPO in Years

5 Solid Dividend Stocks to Buy in July

Pfizer : PFE

All Pfizer Articles

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Biotechs & Pharmas Bracing For ASCO Annual Meeting

DJIA Components Huge Rise in Short Selling (MAY-07)

Short Selling Up in Drug & Medical Stocks

Pre-Market Stock News (May 21, 2007)

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

5 Solid Dividend Stocks to Buy in July

Tesla Robotaxi Success Endangered By Regulators

“You’re Building a Google in 2 Years,” Why One Energy Analyst Warns The U.S. Grid Is Not Ready For What’s Coming

Featured Reads

You Claimed Social Security Back Pay This Year. It Just Nudged You Over the IRMAA Line.

How the Average Retiree's $330,186 Quietly Pushes Their Social Security Into Taxable Territory